Webinar: Spring 2023 COVID-19 Vaccination Updates
Click here to view the archived webinar. On April 18, 2023, the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines were amended to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to […]